A recent study led by Judit Simon from the Department of Health Economics, Center for Public Health, at the Medical University of Vienna shows for the first time comprehensively the extent to which people with mental disorders suffer from physical illnesses—and the resulting hospital costs.
Llama-derived antibodies target coronaviruses’ conserved spike region, offering broad protection
Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants. The unique antibodies target an essential highly conserved site at the base of the virus’s spike protein, effectively clamping it shut and preventing the virus from infecting cells.
Severe forms of COVID-19 infection in children may increase cardiovascular disease risks
New research indicates that children infected with COVID-19 may face increased cardiovascular disease risks indicated by blood plasma metabolic changes.
First-of-its-kind technology helps man with ALS speak in real time
Researchers at the University of California, Davis, have developed an investigational brain-computer interface that holds promise for restoring the voices of people who have lost the ability to speak due to neurological conditions.
Monitoring bone healing without X-ray radiation: A new approach lights the way
A medical research team at Saarland University, led by Professor Bergita Ganse, has discovered a new approach to monitoring bone fracture healing by measuring blood supply to the tissue at the fracture site and the level of oxygen in the blood. Bone regeneration can be monitored quickly and easily using near-infrared light rather than harmful shorter wavelength radiation.
DHEA-S hormone linked to shorter lifespan in men, but not women
A new genetic study suggests that higher levels of the hormone dehydroepiandrosterone sulfate (DHEA-s) are associated with a shorter lifespan in men, but show no significant effect on the lifespan of women.
New immune targets identified in glioblastoma: CD44 and TNFSF14 may help guide future therapies
Glioblastoma (GBM) is the most aggressive and lethal form of brain cancer, with a median survival of only 15 months despite intensive treatment. Current therapies—including surgery, radiation, and chemotherapy—offer limited long-term benefit, and immune-based treatments have so far shown minimal success. The complexity of the tumor’s microenvironment and its ability to suppress immune responses contribute to the poor prognosis.
Prescribing ADHD medications via telehealth does not alter risk of substance use disorder, researchers find
Telehealth can make health care easier to access for patients with attention-deficit/hyperactivity disorder (ADHD) who need treatment, but experts worry about an increased risk of substance use disorder for patients being prescribed controlled medications such as stimulants for ADHD during these appointments.
What allergy remedies really work? Professor debunks myths
As seasons change, temperatures rise and flowers begin to bloom, many find themselves battling more than just spring fever, the feeling of excitement, restlessness or extra energy that individuals may get when spring arrives. From sneezing and itchy eyes to congestion and fatigue, allergies can make this time of year feel like a struggle instead of a fresh start.
Virtual reality could add empathy to dementia care
At a conference on aging two years ago, Li-Mei Chen slipped on a pair of virtual reality (VR) goggles and found herself inside the mind of a person with dementia.